Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016

Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?

(2017) Federico Pea et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance

(2017) Luigi Principe et al.   Journal of Global Antimicrobial Resistance

Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae

(2016) James Albiero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

blaNDM-1Carriage on IncR Plasmid inEnterobacteriaceaeStrains

(2016) Erika Kocsis et al.   Microbial Drug Resistance

Emergence of Klebsiella pneumoniae producing dual carbapenemases (NDM-1 and OXA-232) and 16S rRNA methylase (armA) isolated from a Malaysian patient returning from India

(2015) Farah Al-Marzooq et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control

(2015) T. Tängdén et al.   JOURNAL OF INTERNAL MEDICINE

Carbapenemase-Producing Enterobacteriaceae

(2015) David Paterson et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Investigation of a possible outbreak of NDM-5-producing ST16 Klebsiella pneumoniae among patients in Denmark with no history of recent travel using whole-genome sequencing

(2015) Anette M. Hammerum et al.   Journal of Global Antimicrobial Resistance

First case of multidrug-resistant blaNDM-1- and blaOXA-232-carrying Klebsiella pneumoniae and its probable cross-transmission in a French hospital

(2014) Aurore Bousquet et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013

(2013) C Glasner et al.   Eurosurveillance

Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae

(2013) Anaïs Potron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

New Sequence Types and Multidrug Resistance among Pathogenic Escherichia coli Isolates from Coastal Marine Sediments

(2012) C. Vignaroli et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

(2012) L. S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY REVIEWS

Multiplex PCR for detection of acquired carbapenemase genes

(2011) Laurent Poirel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes

(2011) Matthew E Falagas et al.   Future Microbiology

Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand

(2011) Camilla H. Lester et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS